Neoadjuvant Chemotherapy With Myocet/Taxotere/Herceptin for HER2 Positive Breast Cancer Patients
This study has been completed.
Sponsor:
Spanish Breast Cancer Research Group
Collaborators:
Zeneus Pharma
Sanofi
Hoffmann-La Roche
Amgen
Information provided by:
Spanish Breast Cancer Research Group
ClinicalTrials.gov Identifier:
NCT00129896
First received: August 11, 2005
Last updated: April 27, 2009
Last verified: April 2009
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | December 2007 |
| Estimated Primary Completion Date: | No date given |